Skip to main content

Animations

MJFF Publications

6051 - 6060 of 6514 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: RNApysoforms: fast rendering interactive visualization of RNA isoform structure and expression in Python
    Journal Name: Bioinformatics Advances
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioadv/vbaf057
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Peripheral inflammation’s variable impact on cognitive and symptomatic outcomes in Parkinson’s disease: a longitudinal and cross-sectional analysis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01019-7
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Accurate prediction of absolute prokaryotic abundance from DNA concentration
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2025.101030
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Enrichment analysis for spatial and single-cell metabolomics accounting for molecular ambiguity
    Journal Name: Bioinformatics Advances
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioadv/vbaf100
    Citation Count: 2
  • Summary Details
    OPEN
    Title: NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30175
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00588
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30054
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Characterization of Isolated Human Astrocytes from Aging Brain
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms26073416
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer’s disease
    Journal Name: Nature Cell Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41556-025-01623-y
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Fox Insight: Most Bothersome Symptoms in Early‐Stage Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.14321
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.